Role of Genetic Factors in the Development of Lung Disease

Abroad (travel likely)Recruiting

Conditions

Cystic Fibrosis · Pulmonary Fibrosis · Tuberous Sclerosis · Asthma · Pulmonary Sarcoidosis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Suburban Hospital, Bethesda, Maryland, United States
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Contact: Study coordinator (Tatyana Worthy, B.S.) · worthyt@mail.nih.gov · 301-827-1376

Study leads

Joel Moss, M.D.
Principal Investigator
National Heart, Lung, and Blood Institute (NHLBI)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease

Asthma · COPD · Interstitial Lung Disease

Abroad (travel likely)RecruitingPHASE1

Kansas City, United States

Xenon-129 and Inert Fluorinated Gas Lung MRI: Study of Healthy Volunteers and Participants With Pulmonary Disease

Cystic Fibrosis · Asthma

Abroad (travel likely)RecruitingPHASE2

Toronto, Canada

Acoustic Waveform Respiratory Evaluation

Asthma · COPD · Cystic Fibrosis

Abroad (travel likely)Recruiting

Indianapolis, United States · Pittsburgh, United States

Dose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-581 in Healthy Participants

Cystic Fibrosis

Abroad (travel likely)RecruitingPHASE1

Overland Park, United States